Nabila Tabassum, Kazi Selim Anwar, Probir Kumar Sarkar, A R M Luthful Kabir, Md Abid Hossain Mollah, Dipa Saha, Md Jahangir Alam, Mohammod Jobayer Chisti
{"title":"Vitamin D [<i>Serum 25(OH) cholecalciferol</i>] Insufficiency is Associated With Childhood Asthma: Recent Case-Control Findings From Bangladesh.","authors":"Nabila Tabassum, Kazi Selim Anwar, Probir Kumar Sarkar, A R M Luthful Kabir, Md Abid Hossain Mollah, Dipa Saha, Md Jahangir Alam, Mohammod Jobayer Chisti","doi":"10.1177/2333794X241240574","DOIUrl":null,"url":null,"abstract":"<p><p><i>Objectives.</i> To evaluate the interaction between childhood asthma and <i>S. 25(OH) cholecalciferol</i> among Bangladeshi children. <i>Methods.</i> This case control study was conducted in child asthma clinic, Bangladesh Shishu Hospital Institute during March-August 2021. Comparison was made between clinically-diagnosed (following GINA guideline) asthmatic children (2-12 years-old) (cases = 87) and age and sex-matched children having no respiratory illness (controls = 90) using SPSS' (Statistical Package for Social Science, V.23.0 Windows) software. <i>Results. Serum 25(OH) cholecalciferol</i> was found to be significantly lower among the cases than the controls (<i>P</i> < .01). The cases had 3.4 times higher likelihood of having low vitamin D (combined deficient + insufficient) than the controls (<i>P</i> < .01). <i>Conclusions.</i> The results of the study demonstrate an association of Serum 25 (OH) cholecalciferol with asthma which underscores the importance of potential future trial to evaluate the efficacy of Vitamin-D supplementation for understanding the outcomes of asthmatic Bangladeshi children.</p>","PeriodicalId":12576,"journal":{"name":"Global Pediatric Health","volume":null,"pages":null},"PeriodicalIF":1.4000,"publicationDate":"2024-04-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10993668/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Global Pediatric Health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/2333794X241240574","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"PEDIATRICS","Score":null,"Total":0}
引用次数: 0
Abstract
Objectives. To evaluate the interaction between childhood asthma and S. 25(OH) cholecalciferol among Bangladeshi children. Methods. This case control study was conducted in child asthma clinic, Bangladesh Shishu Hospital Institute during March-August 2021. Comparison was made between clinically-diagnosed (following GINA guideline) asthmatic children (2-12 years-old) (cases = 87) and age and sex-matched children having no respiratory illness (controls = 90) using SPSS' (Statistical Package for Social Science, V.23.0 Windows) software. Results. Serum 25(OH) cholecalciferol was found to be significantly lower among the cases than the controls (P < .01). The cases had 3.4 times higher likelihood of having low vitamin D (combined deficient + insufficient) than the controls (P < .01). Conclusions. The results of the study demonstrate an association of Serum 25 (OH) cholecalciferol with asthma which underscores the importance of potential future trial to evaluate the efficacy of Vitamin-D supplementation for understanding the outcomes of asthmatic Bangladeshi children.